nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—HSPA9—coronary artery disease	0.0225	0.0949	CbGpPWpGaD
Dihydroxyaluminium—VDAC3—cardiac ventricle—coronary artery disease	0.018	0.0718	CbGeAlD
Dihydroxyaluminium—VDAC1—cardiac ventricle—coronary artery disease	0.0171	0.0683	CbGeAlD
Dihydroxyaluminium—VDAC3—myocardium—coronary artery disease	0.017	0.0675	CbGeAlD
Dihydroxyaluminium—VDAC1—myocardium—coronary artery disease	0.0161	0.0642	CbGeAlD
Dihydroxyaluminium—TNNC1—cardiac ventricle—coronary artery disease	0.0147	0.0585	CbGeAlD
Dihydroxyaluminium—VDAC2—heart—coronary artery disease	0.0142	0.0566	CbGeAlD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—TNNI3—coronary artery disease	0.0142	0.0599	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—myocardium—coronary artery disease	0.0138	0.0551	CbGeAlD
Dihydroxyaluminium—VDAC2—cardiovascular system—coronary artery disease	0.0134	0.0534	CbGeAlD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—MYL2—coronary artery disease	0.0125	0.0528	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—HSPD1—coronary artery disease	0.0121	0.0513	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—TNNT2—coronary artery disease	0.0121	0.051	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—TNNI3—coronary artery disease	0.0121	0.0509	CbGpPWpGaD
Dihydroxyaluminium—VDAC3—heart—coronary artery disease	0.0118	0.0471	CbGeAlD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—TTN—coronary artery disease	0.0113	0.0479	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—heart—coronary artery disease	0.0113	0.0448	CbGeAlD
Dihydroxyaluminium—VDAC3—cardiovascular system—coronary artery disease	0.0112	0.0445	CbGeAlD
Dihydroxyaluminium—VDAC1—cardiovascular system—coronary artery disease	0.0106	0.0423	CbGeAlD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—MYL2—coronary artery disease	0.0106	0.0448	CbGpPWpGaD
Dihydroxyaluminium—VDAC2—blood—coronary artery disease	0.0106	0.0422	CbGeAlD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—TNNT2—coronary artery disease	0.0103	0.0433	CbGpPWpGaD
Dihydroxyaluminium—VDAC3—cardiac atrium—coronary artery disease	0.0101	0.0403	CbGeAlD
Dihydroxyaluminium—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—ITGAV—coronary artery disease	0.00988	0.0417	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—heart—coronary artery disease	0.00965	0.0384	CbGeAlD
Dihydroxyaluminium—TNNC1—Striated Muscle Contraction—TTN—coronary artery disease	0.00964	0.0407	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—cardiac atrium—coronary artery disease	0.00963	0.0384	CbGeAlD
Dihydroxyaluminium—TNNC1—Muscle contraction—TNNI3—coronary artery disease	0.00953	0.0402	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—cardiovascular system—coronary artery disease	0.0091	0.0363	CbGeAlD
Dihydroxyaluminium—VDAC3—blood—coronary artery disease	0.00883	0.0352	CbGeAlD
Dihydroxyaluminium—VDAC1—blood—coronary artery disease	0.0084	0.0335	CbGeAlD
Dihydroxyaluminium—TNNC1—Muscle contraction—MYL2—coronary artery disease	0.00839	0.0354	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—cardiac atrium—coronary artery disease	0.00825	0.0329	CbGeAlD
Dihydroxyaluminium—TNNC1—Muscle contraction—TNNT2—coronary artery disease	0.0081	0.0342	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—ITGB3—coronary artery disease	0.00778	0.0328	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—Muscle contraction—TTN—coronary artery disease	0.00762	0.0322	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—blood—coronary artery disease	0.0072	0.0287	CbGeAlD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—PAPPA—coronary artery disease	0.00396	0.0167	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—VKORC1—coronary artery disease	0.00396	0.0167	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—MAPK1—coronary artery disease	0.00328	0.0139	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ADAMTS7—coronary artery disease	0.003	0.0127	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—KLK1—coronary artery disease	0.00286	0.0121	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—HSPA9—coronary artery disease	0.00286	0.0121	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—EIF2AK3—coronary artery disease	0.00275	0.0116	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ACE2—coronary artery disease	0.00228	0.00961	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—TUBA1A—coronary artery disease	0.00222	0.00938	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—KLF4—coronary artery disease	0.00208	0.00879	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—RPL17—coronary artery disease	0.00204	0.00862	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—HSP90B1—coronary artery disease	0.00194	0.00817	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—PLA2G7—coronary artery disease	0.0019	0.00804	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ADAMTS1—coronary artery disease	0.00182	0.00768	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CANX—coronary artery disease	0.00182	0.00768	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—REN—coronary artery disease	0.00172	0.00728	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GATA4—coronary artery disease	0.00168	0.00711	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—HSPD1—coronary artery disease	0.00155	0.00653	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGFBP3—coronary artery disease	0.00131	0.00552	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ACTB—coronary artery disease	0.00129	0.00545	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—F7—coronary artery disease	0.00125	0.00527	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—THBS1—coronary artery disease	0.00119	0.00502	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CALR—coronary artery disease	0.00113	0.00477	CbGpPWpGaD
Dihydroxyaluminium—Vertigo—Valsartan—coronary artery disease	0.0011	0.00216	CcSEcCtD
Dihydroxyaluminium—Back pain—Enalapril—coronary artery disease	0.0011	0.00215	CcSEcCtD
Dihydroxyaluminium—Vertigo—Olmesartan—coronary artery disease	0.0011	0.00215	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Ticagrelor—coronary artery disease	0.0011	0.00214	CcSEcCtD
Dihydroxyaluminium—Chills—Perindopril—coronary artery disease	0.00109	0.00213	CcSEcCtD
Dihydroxyaluminium—Hypotension—Fenofibrate—coronary artery disease	0.00109	0.00212	CcSEcCtD
Dihydroxyaluminium—Back pain—Telmisartan—coronary artery disease	0.00109	0.00212	CcSEcCtD
Dihydroxyaluminium—Infection—Eplerenone—coronary artery disease	0.00108	0.00212	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Lisinopril—coronary artery disease	0.00108	0.00211	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ACE—coronary artery disease	0.00108	0.00455	CbGpPWpGaD
Dihydroxyaluminium—Vertigo—Niacin—coronary artery disease	0.00107	0.0021	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Enalapril—coronary artery disease	0.00107	0.0021	CcSEcCtD
Dihydroxyaluminium—Hypotension—Clopidogrel—coronary artery disease	0.00107	0.00209	CcSEcCtD
Dihydroxyaluminium—Urticaria—Rosuvastatin—coronary artery disease	0.00107	0.00208	CcSEcCtD
Dihydroxyaluminium—Oedema—Simvastatin—coronary artery disease	0.00106	0.00207	CcSEcCtD
Dihydroxyaluminium—Nausea—Penbutolol—coronary artery disease	0.00106	0.00207	CcSEcCtD
Dihydroxyaluminium—Vertigo—Pravastatin—coronary artery disease	0.00106	0.00206	CcSEcCtD
Dihydroxyaluminium—Infection—Simvastatin—coronary artery disease	0.00106	0.00206	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Gemfibrozil—coronary artery disease	0.00104	0.00204	CcSEcCtD
Dihydroxyaluminium—Urticaria—Acetylsalicylic acid—coronary artery disease	0.00103	0.00202	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Captopril—coronary artery disease	0.00103	0.00201	CcSEcCtD
Dihydroxyaluminium—Vertigo—Trandolapril—coronary artery disease	0.00103	0.00201	CcSEcCtD
Dihydroxyaluminium—Back pain—Perindopril—coronary artery disease	0.00103	0.002	CcSEcCtD
Dihydroxyaluminium—Vertigo—Enalapril—coronary artery disease	0.00102	0.002	CcSEcCtD
Dihydroxyaluminium—Hypotension—Eplerenone—coronary artery disease	0.00102	0.00199	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Ticagrelor—coronary artery disease	0.00102	0.00199	CcSEcCtD
Dihydroxyaluminium—Vertigo—Telmisartan—coronary artery disease	0.00101	0.00197	CcSEcCtD
Dihydroxyaluminium—Dizziness—Gemfibrozil—coronary artery disease	0.00101	0.00197	CcSEcCtD
Dihydroxyaluminium—Oedema—Valsartan—coronary artery disease	0.001	0.00196	CcSEcCtD
Dihydroxyaluminium—Oedema—Olmesartan—coronary artery disease	0.000999	0.00195	CcSEcCtD
Dihydroxyaluminium—Infection—Valsartan—coronary artery disease	0.000997	0.00195	CcSEcCtD
Dihydroxyaluminium—Pain—Fenofibrate—coronary artery disease	0.000995	0.00194	CcSEcCtD
Dihydroxyaluminium—Infection—Olmesartan—coronary artery disease	0.000992	0.00194	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000988	0.00193	CcSEcCtD
Dihydroxyaluminium—Dizziness—Ticagrelor—coronary artery disease	0.000985	0.00192	CcSEcCtD
Dihydroxyaluminium—Pain—Clopidogrel—coronary artery disease	0.000978	0.00191	CcSEcCtD
Dihydroxyaluminium—Oedema—Niacin—coronary artery disease	0.000976	0.00191	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Olmesartan—coronary artery disease	0.000975	0.0019	CcSEcCtD
Dihydroxyaluminium—Pain—Lovastatin—coronary artery disease	0.000972	0.0019	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Furosemide—coronary artery disease	0.000971	0.0019	CcSEcCtD
Dihydroxyaluminium—Vomiting—Gemfibrozil—coronary artery disease	0.000969	0.00189	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—PLAUR—coronary artery disease	0.000967	0.00408	CbGpPWpGaD
Dihydroxyaluminium—Back pain—Losartan—coronary artery disease	0.000962	0.00188	CcSEcCtD
Dihydroxyaluminium—Oedema—Pravastatin—coronary artery disease	0.000961	0.00188	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Timolol—coronary artery disease	0.00096	0.00187	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.00096	0.00187	CcSEcCtD
Dihydroxyaluminium—Infection—Pravastatin—coronary artery disease	0.000954	0.00186	CcSEcCtD
Dihydroxyaluminium—Pain—Ezetimibe—coronary artery disease	0.000953	0.00186	CcSEcCtD
Dihydroxyaluminium—Vertigo—Perindopril—coronary artery disease	0.000953	0.00186	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Niacin—coronary artery disease	0.000952	0.00186	CcSEcCtD
Dihydroxyaluminium—Vomiting—Ticagrelor—coronary artery disease	0.000947	0.00185	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—PLG—coronary artery disease	0.000945	0.00399	CbGpPWpGaD
Dihydroxyaluminium—Visual impairment—Ramipril—coronary artery disease	0.000944	0.00184	CcSEcCtD
Dihydroxyaluminium—Hypotension—Valsartan—coronary artery disease	0.000938	0.00183	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Losartan—coronary artery disease	0.000937	0.00183	CcSEcCtD
Dihydroxyaluminium—Hypotension—Olmesartan—coronary artery disease	0.000933	0.00182	CcSEcCtD
Dihydroxyaluminium—Oedema—Trandolapril—coronary artery disease	0.000933	0.00182	CcSEcCtD
Dihydroxyaluminium—Pain—Eplerenone—coronary artery disease	0.000933	0.00182	CcSEcCtD
Dihydroxyaluminium—Oedema—Enalapril—coronary artery disease	0.000929	0.00181	CcSEcCtD
Dihydroxyaluminium—Infection—Trandolapril—coronary artery disease	0.000927	0.00181	CcSEcCtD
Dihydroxyaluminium—Vertigo—Furosemide—coronary artery disease	0.000926	0.00181	CcSEcCtD
Dihydroxyaluminium—Urticaria—Fenofibrate—coronary artery disease	0.000924	0.0018	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Timolol—coronary artery disease	0.000923	0.0018	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Fenofibrate—coronary artery disease	0.00092	0.0018	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Rosuvastatin—coronary artery disease	0.000917	0.00179	CcSEcCtD
Dihydroxyaluminium—Oedema—Telmisartan—coronary artery disease	0.000917	0.00179	CcSEcCtD
Dihydroxyaluminium—Hypotension—Niacin—coronary artery disease	0.000912	0.00178	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Trandolapril—coronary artery disease	0.000911	0.00178	CcSEcCtD
Dihydroxyaluminium—Infection—Telmisartan—coronary artery disease	0.000911	0.00178	CcSEcCtD
Dihydroxyaluminium—Pain—Simvastatin—coronary artery disease	0.000909	0.00177	CcSEcCtD
Dihydroxyaluminium—Urticaria—Clopidogrel—coronary artery disease	0.000909	0.00177	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Enalapril—coronary artery disease	0.000907	0.00177	CcSEcCtD
Dihydroxyaluminium—Nausea—Gemfibrozil—coronary artery disease	0.000906	0.00177	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Clopidogrel—coronary artery disease	0.000904	0.00177	CcSEcCtD
Dihydroxyaluminium—Urticaria—Lovastatin—coronary artery disease	0.000903	0.00176	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Lovastatin—coronary artery disease	0.000898	0.00175	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Telmisartan—coronary artery disease	0.000895	0.00175	CcSEcCtD
Dihydroxyaluminium—Vertigo—Losartan—coronary artery disease	0.000894	0.00174	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000891	0.00174	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Lisinopril—coronary artery disease	0.000891	0.00174	CcSEcCtD
Dihydroxyaluminium—Dizziness—Rosuvastatin—coronary artery disease	0.000887	0.00173	CcSEcCtD
Dihydroxyaluminium—Urticaria—Ezetimibe—coronary artery disease	0.000885	0.00173	CcSEcCtD
Dihydroxyaluminium—Nausea—Ticagrelor—coronary artery disease	0.000885	0.00173	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Ezetimibe—coronary artery disease	0.000881	0.00172	CcSEcCtD
Dihydroxyaluminium—Hypotension—Trandolapril—coronary artery disease	0.000872	0.0017	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Captopril—coronary artery disease	0.00087	0.0017	CcSEcCtD
Dihydroxyaluminium—Hypotension—Enalapril—coronary artery disease	0.000868	0.0017	CcSEcCtD
Dihydroxyaluminium—Oedema—Perindopril—coronary artery disease	0.000865	0.00169	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Eplerenone—coronary artery disease	0.000862	0.00168	CcSEcCtD
Dihydroxyaluminium—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000861	0.00168	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Fenofibrate—coronary artery disease	0.000857	0.00167	CcSEcCtD
Dihydroxyaluminium—Hypotension—Telmisartan—coronary artery disease	0.000856	0.00167	CcSEcCtD
Dihydroxyaluminium—Pain—Olmesartan—coronary artery disease	0.000854	0.00167	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Perindopril—coronary artery disease	0.000845	0.00165	CcSEcCtD
Dihydroxyaluminium—Urticaria—Simvastatin—coronary artery disease	0.000844	0.00165	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Clopidogrel—coronary artery disease	0.000843	0.00165	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Simvastatin—coronary artery disease	0.00084	0.00164	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Lovastatin—coronary artery disease	0.000837	0.00163	CcSEcCtD
Dihydroxyaluminium—Pain—Niacin—coronary artery disease	0.000834	0.00163	CcSEcCtD
Dihydroxyaluminium—Hypotension—Captopril—coronary artery disease	0.000833	0.00163	CcSEcCtD
Dihydroxyaluminium—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000828	0.00162	CcSEcCtD
Dihydroxyaluminium—Pain—Pravastatin—coronary artery disease	0.000822	0.0016	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Ezetimibe—coronary artery disease	0.000821	0.0016	CcSEcCtD
Dihydroxyaluminium—Oedema—Losartan—coronary artery disease	0.000812	0.00158	CcSEcCtD
Dihydroxyaluminium—Hypotension—Perindopril—coronary artery disease	0.000809	0.00158	CcSEcCtD
Dihydroxyaluminium—Infection—Losartan—coronary artery disease	0.000806	0.00157	CcSEcCtD
Dihydroxyaluminium—Urticaria—Valsartan—coronary artery disease	0.000797	0.00156	CcSEcCtD
Dihydroxyaluminium—Chills—Lisinopril—coronary artery disease	0.000797	0.00156	CcSEcCtD
Dihydroxyaluminium—Nausea—Rosuvastatin—coronary artery disease	0.000796	0.00155	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Fenofibrate—coronary artery disease	0.000796	0.00155	CcSEcCtD
Dihydroxyaluminium—Urticaria—Olmesartan—coronary artery disease	0.000793	0.00155	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Losartan—coronary artery disease	0.000792	0.00155	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Olmesartan—coronary artery disease	0.00079	0.00154	CcSEcCtD
Dihydroxyaluminium—Hypotension—Furosemide—coronary artery disease	0.000786	0.00153	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Timolol—coronary artery disease	0.000786	0.00153	CcSEcCtD
Dihydroxyaluminium—Pain—Telmisartan—coronary artery disease	0.000784	0.00153	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Simvastatin—coronary artery disease	0.000783	0.00153	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Clopidogrel—coronary artery disease	0.000783	0.00153	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Lovastatin—coronary artery disease	0.000777	0.00152	CcSEcCtD
Dihydroxyaluminium—Urticaria—Niacin—coronary artery disease	0.000775	0.00151	CcSEcCtD
Dihydroxyaluminium—Nausea—Acetylsalicylic acid—coronary artery disease	0.000774	0.00151	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Niacin—coronary artery disease	0.000771	0.00151	CcSEcCtD
Dihydroxyaluminium—Dizziness—Fenofibrate—coronary artery disease	0.000769	0.0015	CcSEcCtD
Dihydroxyaluminium—Vertigo—Ramipril—coronary artery disease	0.000766	0.0015	CcSEcCtD
Dihydroxyaluminium—Urticaria—Pravastatin—coronary artery disease	0.000763	0.00149	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Ezetimibe—coronary artery disease	0.000762	0.00149	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Pravastatin—coronary artery disease	0.00076	0.00148	CcSEcCtD
Dihydroxyaluminium—Hypotension—Losartan—coronary artery disease	0.000758	0.00148	CcSEcCtD
Dihydroxyaluminium—Dizziness—Clopidogrel—coronary artery disease	0.000756	0.00148	CcSEcCtD
Dihydroxyaluminium—Dizziness—Lovastatin—coronary artery disease	0.000751	0.00147	CcSEcCtD
Dihydroxyaluminium—Vertigo—Timolol—coronary artery disease	0.000749	0.00146	CcSEcCtD
Dihydroxyaluminium—Back pain—Lisinopril—coronary artery disease	0.000748	0.00146	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Eplerenone—coronary artery disease	0.000746	0.00146	CcSEcCtD
Dihydroxyaluminium—Urticaria—Trandolapril—coronary artery disease	0.000741	0.00145	CcSEcCtD
Dihydroxyaluminium—Pain—Perindopril—coronary artery disease	0.00074	0.00144	CcSEcCtD
Dihydroxyaluminium—Vomiting—Fenofibrate—coronary artery disease	0.00074	0.00144	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Valsartan—coronary artery disease	0.000739	0.00144	CcSEcCtD
Dihydroxyaluminium—Convulsion—Ramipril—coronary artery disease	0.000739	0.00144	CcSEcCtD
Dihydroxyaluminium—Urticaria—Enalapril—coronary artery disease	0.000738	0.00144	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Trandolapril—coronary artery disease	0.000738	0.00144	CcSEcCtD
Dihydroxyaluminium—Dizziness—Ezetimibe—coronary artery disease	0.000737	0.00144	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Enalapril—coronary artery disease	0.000735	0.00143	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Lisinopril—coronary artery disease	0.000729	0.00142	CcSEcCtD
Dihydroxyaluminium—Urticaria—Telmisartan—coronary artery disease	0.000728	0.00142	CcSEcCtD
Dihydroxyaluminium—Vomiting—Clopidogrel—coronary artery disease	0.000727	0.00142	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Simvastatin—coronary artery disease	0.000727	0.00142	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Telmisartan—coronary artery disease	0.000725	0.00141	CcSEcCtD
Dihydroxyaluminium—Vomiting—Lovastatin—coronary artery disease	0.000722	0.00141	CcSEcCtD
Dihydroxyaluminium—Dizziness—Eplerenone—coronary artery disease	0.000721	0.00141	CcSEcCtD
Dihydroxyaluminium—Pain—Furosemide—coronary artery disease	0.000719	0.0014	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Niacin—coronary artery disease	0.000719	0.0014	CcSEcCtD
Dihydroxyaluminium—Vomiting—Ezetimibe—coronary artery disease	0.000709	0.00138	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Pravastatin—coronary artery disease	0.000708	0.00138	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Captopril—coronary artery disease	0.000705	0.00138	CcSEcCtD
Dihydroxyaluminium—Dizziness—Simvastatin—coronary artery disease	0.000703	0.00137	CcSEcCtD
Dihydroxyaluminium—Oedema—Ramipril—coronary artery disease	0.000696	0.00136	CcSEcCtD
Dihydroxyaluminium—Vertigo—Lisinopril—coronary artery disease	0.000695	0.00136	CcSEcCtD
Dihydroxyaluminium—Pain—Losartan—coronary artery disease	0.000694	0.00136	CcSEcCtD
Dihydroxyaluminium—Vomiting—Eplerenone—coronary artery disease	0.000693	0.00135	CcSEcCtD
Dihydroxyaluminium—Nausea—Fenofibrate—coronary artery disease	0.000691	0.00135	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—MMP1—coronary artery disease	0.000691	0.00292	CbGpPWpGaD
Dihydroxyaluminium—Urticaria—Perindopril—coronary artery disease	0.000687	0.00134	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Trandolapril—coronary artery disease	0.000687	0.00134	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Valsartan—coronary artery disease	0.000687	0.00134	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Enalapril—coronary artery disease	0.000685	0.00134	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Perindopril—coronary artery disease	0.000684	0.00134	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Olmesartan—coronary artery disease	0.000683	0.00133	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—AGT—coronary artery disease	0.000682	0.00288	CbGpPWpGaD
Dihydroxyaluminium—Oedema—Timolol—coronary artery disease	0.00068	0.00133	CcSEcCtD
Dihydroxyaluminium—Nausea—Clopidogrel—coronary artery disease	0.000679	0.00133	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Ramipril—coronary artery disease	0.000679	0.00133	CcSEcCtD
Dihydroxyaluminium—Infection—Timolol—coronary artery disease	0.000676	0.00132	CcSEcCtD
Dihydroxyaluminium—Vomiting—Simvastatin—coronary artery disease	0.000676	0.00132	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Telmisartan—coronary artery disease	0.000675	0.00132	CcSEcCtD
Dihydroxyaluminium—Nausea—Lovastatin—coronary artery disease	0.000675	0.00132	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—LEP—coronary artery disease	0.000669	0.00282	CbGpPWpGaD
Dihydroxyaluminium—Urticaria—Furosemide—coronary artery disease	0.000668	0.0013	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Niacin—coronary artery disease	0.000668	0.0013	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Furosemide—coronary artery disease	0.000665	0.0013	CcSEcCtD
Dihydroxyaluminium—Dizziness—Valsartan—coronary artery disease	0.000664	0.0013	CcSEcCtD
Dihydroxyaluminium—Nausea—Ezetimibe—coronary artery disease	0.000662	0.00129	CcSEcCtD
Dihydroxyaluminium—Dizziness—Olmesartan—coronary artery disease	0.00066	0.00129	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Pravastatin—coronary artery disease	0.000657	0.00128	CcSEcCtD
Dihydroxyaluminium—Hypotension—Ramipril—coronary artery disease	0.00065	0.00127	CcSEcCtD
Dihydroxyaluminium—Nausea—Eplerenone—coronary artery disease	0.000648	0.00126	CcSEcCtD
Dihydroxyaluminium—Dizziness—Niacin—coronary artery disease	0.000645	0.00126	CcSEcCtD
Dihydroxyaluminium—Urticaria—Losartan—coronary artery disease	0.000645	0.00126	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Losartan—coronary artery disease	0.000642	0.00125	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Trandolapril—coronary artery disease	0.000638	0.00125	CcSEcCtD
Dihydroxyaluminium—Vomiting—Valsartan—coronary artery disease	0.000638	0.00125	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Enalapril—coronary artery disease	0.000636	0.00124	CcSEcCtD
Dihydroxyaluminium—Hypotension—Timolol—coronary artery disease	0.000636	0.00124	CcSEcCtD
Dihydroxyaluminium—Dizziness—Pravastatin—coronary artery disease	0.000635	0.00124	CcSEcCtD
Dihydroxyaluminium—Vomiting—Olmesartan—coronary artery disease	0.000635	0.00124	CcSEcCtD
Dihydroxyaluminium—Nausea—Simvastatin—coronary artery disease	0.000631	0.00123	CcSEcCtD
Dihydroxyaluminium—Oedema—Lisinopril—coronary artery disease	0.000631	0.00123	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—F2—coronary artery disease	0.000631	0.00266	CbGpPWpGaD
Dihydroxyaluminium—Diarrhoea—Telmisartan—coronary artery disease	0.000627	0.00122	CcSEcCtD
Dihydroxyaluminium—Infection—Lisinopril—coronary artery disease	0.000627	0.00122	CcSEcCtD
Dihydroxyaluminium—Vomiting—Niacin—coronary artery disease	0.00062	0.00121	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Furosemide—coronary artery disease	0.00062	0.00121	CcSEcCtD
Dihydroxyaluminium—Dizziness—Trandolapril—coronary artery disease	0.000617	0.0012	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Lisinopril—coronary artery disease	0.000616	0.0012	CcSEcCtD
Dihydroxyaluminium—Dizziness—Enalapril—coronary artery disease	0.000614	0.0012	CcSEcCtD
Dihydroxyaluminium—Vomiting—Pravastatin—coronary artery disease	0.000611	0.00119	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Captopril—coronary artery disease	0.00061	0.00119	CcSEcCtD
Dihydroxyaluminium—Dizziness—Telmisartan—coronary artery disease	0.000606	0.00118	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Losartan—coronary artery disease	0.000598	0.00117	CcSEcCtD
Dihydroxyaluminium—Nausea—Valsartan—coronary artery disease	0.000596	0.00116	CcSEcCtD
Dihydroxyaluminium—Nausea—Olmesartan—coronary artery disease	0.000593	0.00116	CcSEcCtD
Dihydroxyaluminium—Vomiting—Trandolapril—coronary artery disease	0.000593	0.00116	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Perindopril—coronary artery disease	0.000592	0.00116	CcSEcCtD
Dihydroxyaluminium—Vomiting—Enalapril—coronary artery disease	0.000591	0.00115	CcSEcCtD
Dihydroxyaluminium—Hypotension—Lisinopril—coronary artery disease	0.00059	0.00115	CcSEcCtD
Dihydroxyaluminium—Dizziness—Captopril—coronary artery disease	0.000589	0.00115	CcSEcCtD
Dihydroxyaluminium—Vomiting—Telmisartan—coronary artery disease	0.000583	0.00114	CcSEcCtD
Dihydroxyaluminium—Pain—Timolol—coronary artery disease	0.000582	0.00114	CcSEcCtD
Dihydroxyaluminium—Nausea—Niacin—coronary artery disease	0.00058	0.00113	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Furosemide—coronary artery disease	0.000576	0.00112	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—POMC—coronary artery disease	0.000574	0.00243	CbGpPWpGaD
Dihydroxyaluminium—Dizziness—Perindopril—coronary artery disease	0.000572	0.00112	CcSEcCtD
Dihydroxyaluminium—Nausea—Pravastatin—coronary artery disease	0.000571	0.00111	CcSEcCtD
Dihydroxyaluminium—Vomiting—Captopril—coronary artery disease	0.000567	0.00111	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CCL2—coronary artery disease	0.000562	0.00237	CbGpPWpGaD
Dihydroxyaluminium—Dizziness—Furosemide—coronary artery disease	0.000556	0.00109	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Losartan—coronary artery disease	0.000555	0.00108	CcSEcCtD
Dihydroxyaluminium—Nausea—Trandolapril—coronary artery disease	0.000554	0.00108	CcSEcCtD
Dihydroxyaluminium—Urticaria—Ramipril—coronary artery disease	0.000553	0.00108	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGF1—coronary artery disease	0.000553	0.00233	CbGpPWpGaD
Dihydroxyaluminium—Nausea—Enalapril—coronary artery disease	0.000552	0.00108	CcSEcCtD
Dihydroxyaluminium—Vomiting—Perindopril—coronary artery disease	0.00055	0.00107	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Ramipril—coronary artery disease	0.00055	0.00107	CcSEcCtD
Dihydroxyaluminium—Nausea—Telmisartan—coronary artery disease	0.000544	0.00106	CcSEcCtD
Dihydroxyaluminium—Urticaria—Timolol—coronary artery disease	0.000541	0.00106	CcSEcCtD
Dihydroxyaluminium—Pain—Lisinopril—coronary artery disease	0.00054	0.00105	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Timolol—coronary artery disease	0.000538	0.00105	CcSEcCtD
Dihydroxyaluminium—Dizziness—Losartan—coronary artery disease	0.000537	0.00105	CcSEcCtD
Dihydroxyaluminium—Vomiting—Furosemide—coronary artery disease	0.000535	0.00104	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—MMP2—coronary artery disease	0.000535	0.00226	CbGpPWpGaD
Dihydroxyaluminium—Nausea—Captopril—coronary artery disease	0.000529	0.00103	CcSEcCtD
Dihydroxyaluminium—Vomiting—Losartan—coronary artery disease	0.000516	0.00101	CcSEcCtD
Dihydroxyaluminium—Nausea—Perindopril—coronary artery disease	0.000514	0.001	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Ramipril—coronary artery disease	0.000513	0.001	CcSEcCtD
Dihydroxyaluminium—Urticaria—Lisinopril—coronary artery disease	0.000501	0.000979	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Timolol—coronary artery disease	0.000501	0.000979	CcSEcCtD
Dihydroxyaluminium—Nausea—Furosemide—coronary artery disease	0.0005	0.000976	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Lisinopril—coronary artery disease	0.000499	0.000974	CcSEcCtD
Dihydroxyaluminium—Nausea—Losartan—coronary artery disease	0.000482	0.000941	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Ramipril—coronary artery disease	0.000476	0.00093	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Timolol—coronary artery disease	0.000466	0.000909	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Lisinopril—coronary artery disease	0.000465	0.000908	CcSEcCtD
Dihydroxyaluminium—Dizziness—Ramipril—coronary artery disease	0.00046	0.000899	CcSEcCtD
Dihydroxyaluminium—Dizziness—Timolol—coronary artery disease	0.00045	0.000878	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CXCL8—coronary artery disease	0.000444	0.00188	CbGpPWpGaD
Dihydroxyaluminium—Vomiting—Ramipril—coronary artery disease	0.000443	0.000864	CcSEcCtD
Dihydroxyaluminium—Vomiting—Timolol—coronary artery disease	0.000433	0.000845	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Lisinopril—coronary artery disease	0.000432	0.000843	CcSEcCtD
Dihydroxyaluminium—Dizziness—Lisinopril—coronary artery disease	0.000417	0.000815	CcSEcCtD
Dihydroxyaluminium—Nausea—Ramipril—coronary artery disease	0.000413	0.000807	CcSEcCtD
Dihydroxyaluminium—Nausea—Timolol—coronary artery disease	0.000404	0.000789	CcSEcCtD
Dihydroxyaluminium—Vomiting—Lisinopril—coronary artery disease	0.000401	0.000784	CcSEcCtD
Dihydroxyaluminium—Nausea—Lisinopril—coronary artery disease	0.000375	0.000732	CcSEcCtD
